Lv41
524 积分 2024-09-11 加入
Multidrug-resistant Gram-negative bacterial infections
4小时前
已完结
Innovations in Psoriasis
3天前
已完结
Disease modification in inflammatory skin disorders: opportunities and challenges
3天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
3天前
已完结
The next generation of immunotherapies for lung cancers
3天前
已完结
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834
11天前
已完结
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
11天前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
13天前
已完结
Antibody–drug conjugates in urothelial carcinoma: current status and future
14天前
已完结
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non–Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834
25天前
已完结
皖公网安备34019202002308
